Φορτώνει......
Nutlin-3 enhances the bortezomib sensitivity of p53-defective cancer cells by inducing paraptosis
The proteasome inhibitor, bortezomib, is ineffective against many solid tumors. Nutlin-3 is a potent antagonist of human homolog of murine double minute 2/p53 interaction exhibiting promising therapeutic anti-cancer activity. In this study, we show that treatment of various p53-defective bortezomib-...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Exp Mol Med |
|---|---|
| Κύριοι συγγραφείς: | , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Nature Publishing Group
2017
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5579507/ https://ncbi.nlm.nih.gov/pubmed/28798402 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/emm.2017.112 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|